Literature DB >> 12453885

Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?

Charlotte Lamandin, Christophe Sagot, Christophe Roumier, Pascale Lepelley, Stéphane De Botton, Alain Cosson, Pierre Fenaux, Claude Preudhomme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12453885     DOI： 10.1182/blood-2002-08-2563

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  RUNX1 regulates corepressor interactions of PU.1.

Authors:  Zhenbo Hu; Xiaorong Gu; Kristine Baraoidan; Vinzon Ibanez; Arun Sharma; ShriHari Kadkol; Reinhold Munker; Steven Ackerman; Giuseppina Nucifora; Yogen Saunthararajah
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

Review 2.  Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.

Authors:  Steffen Koschmieder; Frank Rosenbauer; Ulrich Steidl; Bronwyn M Owens; Daniel G Tenen
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

3.  Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.

Authors:  Donald Metcalf; Aleksandar Dakic; Sandra Mifsud; Ladina Di Rago; Li Wu; Stephen Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.

Authors:  Beatrice U Mueller; Thomas Pabst; José Fos; Vibor Petkovic; Martin F Fey; Norio Asou; Ulrich Buergi; Daniel G Tenen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

Review 5.  Effect of transcription-factor concentrations on leukemic stem cells.

Authors:  Frank Rosenbauer; Steffen Koschmieder; Ulrich Steidl; Daniel G Tenen
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

6.  The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias.

Authors:  Vincent-Philippe Lavallée; Irène Baccelli; Jana Krosl; Brian Wilhelm; Frédéric Barabé; Patrick Gendron; Geneviève Boucher; Sébastien Lemieux; Anne Marinier; Sylvain Meloche; Josée Hébert; Guy Sauvageau
Journal:  Nat Genet       Date:  2015-08-03       Impact factor: 38.330

7.  A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.

Authors:  Timothy J Ley; Patrick J Minx; Matthew J Walter; Rhonda E Ries; Hui Sun; Michael McLellan; John F DiPersio; Daniel C Link; Michael H Tomasson; Timothy A Graubert; Howard McLeod; Hanna Khoury; Mark Watson; William Shannon; Kathryn Trinkaus; Sharon Heath; James W Vardiman; Michael A Caligiuri; Clara D Bloomfield; Jeffrey D Milbrandt; Elaine R Mardis; Richard K Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

8.  Genome-scale definition of the transcriptional programme associated with compromised PU.1 activity in acute myeloid leukaemia.

Authors:  J I Sive; S Basilico; R Hannah; S J Kinston; F J Calero-Nieto; B Göttgens
Journal:  Leukemia       Date:  2015-07-01       Impact factor: 11.528

9.  Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells.

Authors:  C-H Olme; N Brown; R Finnon; S D Bouffler; C Badie
Journal:  Mutat Res       Date:  2013-05-09       Impact factor: 2.433
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.